Heron Therapeutics, Inc. Share Price

Heron Therapeutics, Inc. Share Price

NASDAQ: HRTX | Micro Cap
$0.29
-$0.02 (-4.94%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Heron Therapeutics, Inc. Stock Performance

Open
$0.31
Prev. Close
$0.31
Circuit Range
N/A
Day Range
$0.29 - $0.31
Year Range
$0.26 - $1.56
Volume
3,465
Average Traded
$0.30

Heron Therapeutics, Inc. Share Price Today

As of 30 October 2026, Heron Therapeutics, Inc.'s share price is $0.29. The stock opened at $0.31, compared to its previous close of $0.31. During today's trading session, Heron Therapeutics, Inc.'s share price traded between $0.29 and $0.31, with an average price of $0.30. Over the past 52 weeks, the stock has recorded a high of $1.56 and a low of $0.26. In terms of performance, Heron Therapeutics, Inc.'s share price has declined by 75.57% over the last six months and is down 74.40% on a year-on-year basis.

Heron Therapeutics, Inc. Share Price Chart

Line chart of the Heron Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 0.29 to 0.31, ending at 0.29.
$0.29$0.31
L
Show Current Price
H

Heron Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$49.08M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.18
Revenue (TTM)
$154.90B
Return On Equity (TTM)
-492.89%
Profit Margin
-13.04%
Debt to Equity
20.65
Quarterly Earnings Growth YoY
68.63%

Heron Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$38.21$40.59$34.71$37.67
Net Profit-$17.50-$2.95-$8.11-$5.49
Net Profit Margin-45.80%-7.27%-23.37%-14.57%
Income ChangeN/A83.14%-174.92%32.31%

Heron Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$107.67$127.04$144.29$154.90
Net Profit-$182.02-$110.56-$13.58-$20.20
Net Profit Margin-169.05%-87.03%-9.41%-13.04%
Income ChangeN/A39.26%87.72%-48.75%

About Heron Therapeutics, Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Heron Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.32
$0.29
-8.13%
Sep 2026
$0.32
$0.32
-3.61%
Aug 2026
$0.50
$0.33
-33.33%
Jul 2026
$0.43
$0.50
+16.63%
Jun 2026
$0.88
$0.43
-50.64%
May 2026
$1.22
$0.86
-28.22%
Apr 2026
$0.81
$1.21
+51.38%
Mar 2026
$1.18
$0.80
-33.67%
Feb 2026
$1.32
$1.20
-9.43%
Jan 2026
$1.30
$1.32
+2.32%
Dec 2025
$1.14
$1.29
+12.12%
Nov 2025
$1.19
$1.16
+0.43%

HRTX Share Price FAQs